Physician profile
Fernando A Herrera
NPI 1013164243
$16,422.84
in general payments reported to CMS, 2019-2025
21 companies · $495 in 2025
The $495 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,160 · 2020: $5,404 · 2021: $1,166 · 2022: $5,120 · 2023: $1,133 · 2024: $945 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,572.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $3,000.63 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Musculoskeletal Transplant Foundation INC. | $2,956.62 | 2020-2025 | |
| Axogen | $2,212.06 | 2019-2022 | |
| Allergan, INC. | $2,208.05 | 2019-2022 | |
| Peerless Surgical INC. | $1,652.29 | 2019-2020 | |
| Mentor Worldwide LLC | $768.86 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Sientra, INC. | $737.62 | 2021-2022 | |
| Integra Lifesciences Corporation | $636.43 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acera Surgical, INC. | $428.47 | 2019-2023 | Restrata Wound Matrix |
| Abbvie INC. | $379.96 | 2023-2024 | |
| Medtronic, INC. | $343.49 | 2024 | Plasmablade(Tm) |
| Smith+Nephew, INC. | $210.14 | 2023-2024 | Stravix, Grafix Pl |
| Access Pro Medical, LLC | $184.18 | 2023 | Matriderm |
| Kci USA, INC. | $172.16 | 2022-2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo |
| Sanara Medtech INC. | $151.66 | 2025 | Celleraterx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $122.46 | 2019 | |
| Depuy Synthes Sales INC. | $115.73 | 2024 | Trumatch |
| Exsomed Corporation | $63.61 | 2021 | |
| Skeletal Dynamics INC | $60.13 | 2024-2025 | Implate, Geminus, Ijs |
| Sonex Health, INC. | $12.90 | 2022 | |
| Checkpoint Surgical, INC | $5.39 | 2025 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Herrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.